BioCentury | Oct 16, 2014
Company News

Chimerix gives update on brincidofovir, CMX16669

...viral infections in an R&D update. The company also plans to file an IND for CMX16669...
...year end for CMX16669 to treat CMV and begin clinical trials in 2015. He said CMX16669...
...uridine substitution that may lower the probability of genetic liabilities, and that low doses of CMX16669...
Items per page:
1 - 1 of 1